These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29191723)

  • 1. Botulinum Toxin for Painful Torticollis in Leptomeningeal Disease: Case Report.
    Selby D; Nguyen M; Toor H
    J Pain Symptom Manage; 2018 May; 55(5):e7-e9. PubMed ID: 29191723
    [No Abstract]   [Full Text] [Related]  

  • 2. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 3. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local treatment of spasmodic torticollis with botulinum toxin.
    Tsui JK; Fross RD; Calne S; Calne DB
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):533-5. PubMed ID: 3676924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social phobia in spasmodic torticollis: some conceptual issues.
    Sharma P; Gupta N
    J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):461; author reply 461-2. PubMed ID: 12235327
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 8. Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.
    Lew MF
    Adv Neurol; 2004; 94():211-5. PubMed ID: 14509675
    [No Abstract]   [Full Text] [Related]  

  • 9. [Botulinum toxin in the treatment of pain].
    Domzał TM
    Neurol Neurochir Pol; 1998; 32 Suppl 1():57-60. PubMed ID: 9608554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic side effects of botulinum toxin type B therapy.
    Dressler D; Benecke R
    Adv Neurol; 2004; 94():315-20. PubMed ID: 14509689
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasticity of static graviceptive function in patients with cervical dystonia.
    Platho-Elwischger K; Kranz G; Sycha T; Dunkler D; Rommer P; Mueller C; Auff E; Wiest G
    J Neurol Sci; 2017 Feb; 373():230-235. PubMed ID: 28131194
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure.
    Dressler D; Bigalke H; Benecke R
    J Neurol; 2003 Aug; 250(8):967-9. PubMed ID: 12928917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
    Jankovic J; Hunter C; Dolimbek BZ; Dolimbek GS; Adler CH; Brashear A; Comella CL; Gordon M; Riley DE; Sethi K; Singer C; Stacy M; Tarsy D; Atassi MZ
    Neurology; 2006 Dec; 67(12):2233-5. PubMed ID: 17190952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis.
    Singer C; Papapetropaulos S; Ayyar DR; Verma A
    Mov Disord; 2007 Jan; 22(2):289. PubMed ID: 17094101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cervical Dystonia].
    Reichel G; Kamm C; Kang JS; Müngersdorf M; Paus S; Reuter I; Stenner A; Weise D
    Fortschr Neurol Psychiatr; 2018 Jun; 86(6):368-386. PubMed ID: 29954019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of selective ramisectomy for botulinum toxin resistant torticollis.
    Ford B; Louis ED; Greene P; Fahn S
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):472-8. PubMed ID: 9771768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.
    Dressler D; Bigalke H
    J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.